Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
21.96
+0.29 (1.34%)
At close: Mar 7, 2025, 4:00 PM
21.85
-0.11 (-0.50%)
After-hours: Mar 7, 2025, 8:38 PM EST
Catalyst Pharmaceuticals Employees
Catalyst Pharmaceuticals had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$2,716,762
Profits / Employee
$905,464
Market Cap
2.67B
Employees Chart
CPRX News
- 5 days ago - Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference - GlobeNewsWire
- 6 days ago - Catalyst Pharmaceuticals: Stable Firdapse, Promising Agamree, Fycompa Challenges - Seeking Alpha
- 10 days ago - Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 25 days ago - Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 - GlobeNewsWire
- 4 weeks ago - Catalyst Remains a Big Money Favorite - FXEmpire
- 6 weeks ago - Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies - GlobeNewsWire
- 6 weeks ago - Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan - GlobeNewsWire